Alnylam Pharmaceuticals (ALNY) EBT (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.96% |
| Dec 31, 2025 | -69.25% |
| Sep 30, 2025 | 893.51% |
| Jun 30, 2025 | -1,393.16% |
| Mar 31, 2025 | 98.78% |
| Dec 31, 2024 | -78.49% |
| Sep 30, 2024 | -873.07% |
| Jun 30, 2024 | 82.44% |
| Mar 31, 2024 | 53.82% |
| Dec 31, 2023 | -191.34% |
| Sep 30, 2023 | 154.97% |
| Jun 30, 2023 | -59.09% |
| Mar 31, 2023 | 16.74% |
| Dec 31, 2022 | 49.00% |
| Sep 30, 2022 | -47.79% |
| Jun 30, 2022 | -14.76% |
| Mar 31, 2022 | 8.05% |
| Dec 31, 2021 | -27.45% |
| Sep 30, 2021 | -8.45% |
| Jun 30, 2021 | 5.49% |
| Mar 31, 2021 | 18.20% |
| Dec 31, 2020 | 3.51% |
| Sep 30, 2020 | -41.90% |
| Jun 30, 2020 | 2.06% |
| Mar 31, 2020 | 34.32% |
| Dec 31, 2019 | -32.38% |
| Sep 30, 2019 | 4.39% |
| Jun 30, 2019 | -20.58% |
| Mar 31, 2019 | 14.15% |
| Dec 31, 2018 | 13.79% |
| Sep 30, 2018 | -49.76% |
| Jun 30, 2018 | -15.72% |
| Mar 31, 2018 | 0.67% |
| Dec 31, 2017 | -15.69% |
| Sep 30, 2017 | -3.81% |
| Jun 30, 2017 | -10.37% |
| Mar 31, 2017 | 5.25% |
| Dec 31, 2016 | -8.39% |
| Sep 30, 2016 | -15.91% |
| Jun 30, 2016 | 12.47% |
| Mar 31, 2016 | -13.51% |
| Dec 31, 2015 | -18.14% |
| Sep 30, 2015 | -7.62% |
| Jun 30, 2015 | -39.34% |
| Mar 31, 2015 | -17.77% |
| Dec 31, 2014 | 1.01% |
| Sep 30, 2014 | 1.05% |
| Jun 30, 2014 | 83.49% |
| Mar 31, 2014 | -816.32% |
| Dec 31, 2013 | 8.20% |
| Sep 30, 2013 | -51.79% |
| Jun 30, 2013 | -119.87% |
| Mar 31, 2013 | -121.94% |
| Dec 31, 2012 | 323.77% |
| Sep 30, 2012 | -50.52% |
| Jun 30, 2012 | -13.97% |
| Mar 31, 2012 | -126.33% |
| Dec 31, 2011 | 426.19% |
| Sep 30, 2011 | 4.25% |
| Jun 30, 2011 | 15.11% |
| Mar 31, 2011 | -150.42% |
| Dec 31, 2010 | 30.32% |
| Sep 30, 2010 | 37.20% |
| Jun 30, 2010 | -20.77% |
| Mar 31, 2010 | -49.51% |
| Dec 31, 2009 | 15.68% |
| Sep 30, 2009 | 55.22% |